Journal profile · CARDIAC & CARDIOVASCULAR SYSTEMS
Cardiovascular Innovations and Applications
ISSN 2009-8618 · eISSN 2009-8782 · Compuscript · Ireland
Cardiovascular Innovations and Applications: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.4 (journal website); diamond open access (no APC); no APC; review about 16 weeks (community reports); 46 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Cardiovascular Innovations and Applications is published by Compuscript and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cardiac Imaging and Diagnostics, Coronary Interventions and Diagnostics and Cardiovascular Function and Risk Factors, together about 25% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Cardiovascular Innovations and Applications (CVIA) is a peer-reviewed, platinum open-access journal publishing focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicability in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, prevention of cardiovascular disease with a heavy emphasis on risk factor modification. Cardiovascular Innovations and Applications (CVIA) also welcomes state-of-the-art review articles, commentaries, case studies and reports, letters to the editor, methodology papers related to clinical trials, education and training articles, techniques and videos.
From the journal's Aims & Scope
Research area (LetPub): CARDIAC & CARDIOVASCULAR SYSTEMS
Editor-in-chief Jamie B. ContiPublisher website
Editorial board by country: 46 in mainland China (about 49%); most named Mainland China 46, United States 23, Italy 8, Netherlands 2, Türkiye 2 (94 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cardiac Imaging and DiagnosticsMedicine9.3%
- Coronary Interventions and DiagnosticsMedicine8.3%
- Cardiovascular Function and Risk FactorsMedicine7.3%
- Cardiac Valve Diseases and TreatmentsMedicine7%
- Cardiac Arrhythmias and TreatmentsMedicine6.6%
- Acute Myocardial Infarction ResearchMedicine5.3%
- Atrial Fibrillation Management and OutcomesMedicine5%
- Cardiac Structural Anomalies and RepairMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
Other: EBSCO, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), Index Copernicus, Research4Life, CNKI Scholar (Chinese National Knowledge Infrastructure)
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.4Publisher website ·
- CiteScore 2026-06
- 2.6LetPub ·
- CiteScore (publisher)
- 1.2Publisher website ·
- SJR 2026-06
- 0.53LetPub ·
- SNIP 2026-06
- 0.5LetPub ·
- h-index
- 12OpenAlex ·
- i10-index
- 20OpenAlex ·
- 2-year mean citedness
- 1.71OpenAlex ·
- Self-citation rate
- 3.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 30LetPub ·
Articles by year OpenAlex count · 529 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 39 | 39 | 13 |
| 2025 | 46 | 46 | 60 |
| 2024 | 76 | 76 | 202 |
| 2023 | 80 | 80 | 352 |
| 2022 | 23 | 23 | 110 |
| 2021 | 32 | 32 | 89 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 16 weeksLetPub ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted7
- case studies and reportsCardiovascular Innovations and Applications (CVIA) also welcomes state-of-the-art review articles, commentaries, case studies and reports, letters to the editor…Length not stated
- commentariesCardiovascular Innovations and Applications (CVIA) also welcomes state-of-the-art review articles, commentaries, case studies and reports, letters to the editor…Length not stated
- education and training articlesCardiovascular Innovations and Applications (CVIA) also welcomes state-of-the-art review articles, commentaries, case studies and reports, letters to the editor…Length not stated
- letters to the editorCardiovascular Innovations and Applications (CVIA) also welcomes state-of-the-art review articles, commentaries, case studies and reports, letters to the editor…Length not stated
- methodology papers related to clinical trialsCardiovascular Innovations and Applications (CVIA) also welcomes state-of-the-art review articles, commentaries, case studies and reports, letters to the editor…Length not stated
- state-of-the-art review articlesCardiovascular Innovations and Applications (CVIA) also welcomes state-of-the-art review articles, commentaries, case studies and reports, letters to the editor…Length not stated
- techniques and videosCardiovascular Innovations and Applications (CVIA) also welcomes state-of-the-art review articles, commentaries, case studies and reports, letters to the editor…Length not stated
Policy excerpts from the journal's websiteConflicts of interest, Open access, Preprints
- Conflicts of interest Disclosures
Each author must disclose all financial relationship related to the subject of the paper. Model summary
Each author must disclose all financial relationship related to the subject of the paper. This should include equity ownership, profit-sharing agreements, royalties, patents, and grants. Income from pharmaceutical companies should be specified by type, e.g. speaker’s honoraria, expenses, grants, etc. Authors do not need to report the sums concerned. If none, state “none”.
Source ↗Publisher website ·- Open access
CVIA does not impose any article processing charges (APC) or submission charges. Model summary
CVIA does not impose any article processing charges (APC) or submission charges.
Source ↗Publisher website ·- Preprints
The Journal will not consider papers that have been accepted for publication or published elsewhere. Model summary
The Journal will not consider papers that have been accepted for publication or published elsewhere.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Compuscript
- Country or region
- Ireland
- Language
- English
- ISSN
- 2009-8618
- Electronic ISSN
- 2009-8782
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cardiovascular Innovations and Applications
What CAS zone is Cardiovascular Innovations and Applications in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cardiovascular Innovations and Applications is in Zone 4 of Medicine, and in Zone 4 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cardiovascular Innovations and Applications?
The journal's website gives an impact factor of 1.4; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.6, h-index 12.
How long does peer review take at Cardiovascular Innovations and Applications?
Authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Cardiovascular Innovations and Applications based?
Of the 94 board members whose country the journal's board page names, 46 (about 49%) are in mainland China; the countries named most often are Mainland China (46), United States (23) and Italy (8). Counted from the institutions listed on the board page; for reference only.
Which databases index Cardiovascular Innovations and Applications?
According to LetPub and DOAJ records, Cardiovascular Innovations and Applications is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Embase; that list has not been checked against each database.
Is Cardiovascular Innovations and Applications open access, and what is the APC?
Cardiovascular Innovations and Applications is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .